T46.4X5A
Billable
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T46.4X5A is billable and can be used for reimbursement purposes.
AI Search
Analyze diagnoses and doctors notes
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T46.4X5A is billable and can be used for reimbursement purposes.